Olive Bio Therapeutics
PrivateLast Round
Seed
Jul 1, 2023
Company Overview
Olive Bio Therapeutics operates in Healthcare & Life Sciences and is based in Gwangju. Its latest recorded funding round was a Seed round in July 2023.
Olive Bio Therapeutics is a biotechnology company that develops gene and protein therapeutics for the treatment of age-related macular degeneration.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Olive Bio Therapeutics Comparables
Compare Olive Bio Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Celliaz Co., Ltd. | 91% | |
| Ikarovec | 85% | |
| Cirrus Therapeutics | 84% |
For institutional investors. Book with your work email.
Olive Bio Therapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Olive Bio Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| The Innovators | Seed |
| Sunbo Angel Partners | Seed |
| TIPS (Tech Incubator Program for Startup) | Seed |
| IBK Changgong | Seed |
| ROWE Partners | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 1, 2023
Raised capital from Sunbo Angel Partners and other investors.
For institutional investors. Book with your work email.
Olive Bio Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Olive Bio Therapeutics's valuation, stock price, and market status.
Is Olive Bio Therapeutics a public or private company?
Olive Bio Therapeutics is a private company.
What is the current stock price of Olive Bio Therapeutics?
Olive Bio Therapeutics is a private company, so its shares have no public market price. Caplight tracks Olive Bio Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Olive Bio Therapeutics worth (valuation)?
Valuation information for Olive Bio Therapeutics is not publicly available.
Can I buy Olive Bio Therapeutics stock?
Olive Bio Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Olive Bio Therapeutics's last funding round?
Olive Bio Therapeutics's most recent funding round was Seed on July 1, 2023.
Who are the main investors in Olive Bio Therapeutics?
Key investors in Olive Bio Therapeutics include The Innovators, Sunbo Angel Partners, TIPS (Tech Incubator Program for Startup), IBK Changgong, ROWE Partners.
Will Olive Bio Therapeutics IPO soon?
No public IPO plans have been announced for Olive Bio Therapeutics.
How can I track Olive Bio Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Olive Bio Therapeutics's shares on secondary markets.